Shoulder Innovations, Inc. (SI)
NYSE · Healthcare
$19.60+3.10%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $408M
- P/E (trailing)
- 24.2
- 52-week range
- $10.92 – $24.60
- 52-week change
- +45.11%
- EPS (trailing)
- $0.81
- Analyst rating
- 1.3 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $47.3M (+49.63%)
- Net income
- −$40.4M
- Operating margin
- −55.6%
- Diluted EPS
- −$4.65
- Free cash flow
- −$36.0M
From the company’s annual report on SEC EDGAR.